Rosuvastatin for sepsis-associated acute respiratory distress syndrome
about
Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysisDesigning phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failureSepsis and Acute Respiratory Distress Syndrome: Recent UpdateExploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular DiseaseEmerging therapies for the prevention of acute respiratory distress syndromeAKI associated with cardiac surgery.Acute respiratory distress syndrome following cardiovascular surgery: current concepts and novel therapeutic approachesTreating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung diseaseHepatic Shock Differential Diagnosis and Risk Factors: A Review ArticleThe acute respiratory distress syndrome: from mechanism to translationStatin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations.Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.Simvastatin-induced sphingosine 1-phosphate receptor 1 expression is KLF2-dependent in human lung endothelial cells.Is there a need for emerging drugs for the acute respiratory distress syndrome?The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation.Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis.Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis.Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin.Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor BlockersAPACHE III Outcome Prediction in Patients Admitted to the Intensive Care Unit with Sepsis Associated Acute Lung Injury.Prognostic Implications of Serum Lipid Metabolism over Time during SepsisExtremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome.Comparison of community-acquired, hospital-acquired, and intensive care unit-acquired acute respiratory distress syndrome: a prospective observational cohort study.Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis.PEEP titration during prone positioning for acute respiratory distress syndrome.Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome: a retrospective cohort study.High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.The association of statin therapy with the risk of recurrent venous thrombosis.A Stromal Cell-derived Factor 1 alpha Analogue Improves Endothelial Cell Function in Lipopolysaccharide-induced Acute Respiratory Distress SyndromeSystematic review of statins in sepsis: There is no evidence of dose response.Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.Emerging drugs for acute lung injury.Update in sepsis and acute kidney injury 2014.
P2860
Q26746082-76C99B93-45F2-4D99-A7C9-C32CC799AB05Q26749027-713E6DFE-1FAF-4554-AED7-3A58A84DB3E5Q26749485-B1D00A86-A4C9-4844-AD5A-1210895506E3Q26801173-C0DAF288-3418-4898-9DA0-E6E154CAF520Q26822605-B0A41B0C-8AEC-4C27-9806-E1546BDC5577Q27023234-F7C8DD49-E523-4BDE-9865-7A8F41C5846BQ27693319-1DB9FE73-C671-4F6B-8B2C-2C07614105C5Q28076034-5E9E2B05-63BB-4149-8EF0-EEB6603B1D5DQ28085094-FDB89C67-0525-41A8-B6D8-81C83303F3F0Q28088482-FD8F9720-1024-469D-97CD-E5ED36CF49C4Q28386068-F2A5BC20-894D-4C85-963B-2E809BB3BD44Q30375212-318805C7-A25C-448F-B47D-E97D0F463BF6Q31150571-00C08BCB-463F-4838-9299-17010C5F3D7AQ33623532-AAD741CC-676D-4D2D-B92B-EE26E432B2D3Q33738580-CAFF4D08-650D-4465-BF5A-105DB8D0B01EQ34823885-4005DCDF-70FD-40C1-8976-7CF484E3D986Q34903761-488AEE1E-8C29-4E40-AD0E-655993A461FDQ35152144-9B4C0F2A-8E8B-4D2B-98E6-103E34B4D8A3Q35211647-15D89246-78F7-49FC-9341-54E5D91AB6B9Q35597977-4D2FE225-C538-47D4-A777-3CFDD9D1C339Q35603020-805DC6F0-A8E6-4021-B31C-993815BE7492Q35649119-D0050F5A-E65E-4AD1-BA9E-D65A87FC1166Q35777761-600CE5FF-773D-4BDD-9FBB-10EF5B04F655Q35793850-6AA7D059-C2DE-4154-ACDA-98156C6182F1Q36006620-350EDB8D-FB4E-43A8-977E-B0CFE546972CQ36126260-C057EBC6-3FF5-40DB-A210-BFFA8D19CD79Q36247214-C727BF5A-1CC9-473C-843E-CAE0F3F078BFQ36298592-1DD709BB-62F2-4E5C-8679-EEA877E0F715Q36340320-3D557FC0-BF30-455B-A919-F4CE3D9ED810Q36424737-8A728513-50F1-4FA9-9963-DBB9F36C36E1Q36689726-E71D1B25-3BA7-43BA-9F5D-B77174CBC9EBQ36760163-112D9F42-29CD-4574-A6FA-548EF6DCC242Q36832295-948286F5-B164-4D7F-87B4-709198D4533DQ37138335-55C968B5-54A0-4F32-BF13-B318915736CEQ37217018-D7C4A00F-88E2-4C22-AEC1-34C0F3B87B15Q37265029-4BF6B1EB-CC25-4FD1-9206-5A853847B780Q37644140-9B7BBCEA-C5FB-49B3-AA2F-E0BA7F03A7B1Q37721117-3AAD9113-EF7D-4F5D-B709-5E6D601228C9Q38308143-4D58B99F-8BF0-4953-870F-344FEDF1DA54Q38510417-95FDA313-5206-4356-AF98-4C7952F47014
P2860
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@ast
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@en
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@nl
type
label
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@ast
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@en
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@nl
prefLabel
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@ast
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@en
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@nl
P2093
P2860
P356
P1476
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
@en
P2093
B Taylor Thompson
Bennett P deBoisblanc
Carl Shanholtz
Catherine L Hough
Gordon R Bernard
Ivor S Douglas
Jay Steingrub
Jonathon D Truwit
Kathleen D Liu
National Heart, Lung, and Blood Institute ARDS Clinical Trials Network
P2860
P304
P356
10.1056/NEJMOA1401520
P407
P577
2014-05-18T00:00:00Z